We report the synthesis of Au(I) and Au(III) complexes, involving alcohol functionalized bis(N-heterocyclic carbene) ligands. Two short reaction pathways lead to the diimidazolium precursors, namely 1,1′-(2,6-pyridinediyl)bis[3-(2-hydroxyethyl)-1H-imidazol-3-ium]diiodide (2), 3,3′(methanediyl)bis[1-(2-hydroxy-2-methylpropyl)-1H-imidazol-3-ium]dibromide (4) and 3,3′-(1,3-propanediyl)bis[1-(2-hydroxy-2-methylpropyl)-1H-imidazol-3-ium]bis(4-methylbenzenesulfonate) (6), in which the two azolium rings are bridged by a rigid pyridine unit or an aliphatic chain (C1 or C3). The Au(I) complexes [AuI(Lpy)]22+[PF6−]2 (11) and [AuI(LC1)]22+[PF6−]2 (13) were obtained by direct metallation of the salts 2 and 4, respectively, in the presence of sodium acetate with Au(SMe2)Cl, followed by an anionic metathesis in the presence of KPF6. The trimethylene compound [AuI(LC3)]22+[PF6−]2 (15) was prepared by transmetallation between the related precursor [AgI(LC3)]22+[PF6−]2 (10) and Au(SMe2)Cl. The Au(III) complexes, [AuIII(Lpy)Br2]22+[PF6−]2 (16), [AuIII(LC1)Br2]22+[PF6−]2 (17) and [AuIII(LC3)Br2]22+[PF6−]2 (18) were generated by oxidation of the corresponding Au(I) species with an excess of elemental bromine. Complexes 11, [AuI(LC1)]22+ [Br−]2 (12) and 15 have been characterized by single-crystal X-ray diffraction analyses. The electrochemical and luminescence properties of the Au(I) and Au(III) compounds have been studied.
The global spread of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has called for an urgent need for dedicated antiviral therapeutics. Metal complexes are commonly underrepresented in compound libraries that are used for screening in drug discovery campaigns, however, there is growing evidence for their role in medicinal chemistry. Based on previous results, we have selected more than 100 structurally diverse metal complexes for profiling as inhibitors of two relevant SARS‐CoV‐2 replication mechanisms, namely the interaction of the spike (S) protein with the ACE2 receptor and the papain‐like protease PLpro. In addition to many well‐established types of mononuclear experimental metallodrugs, the pool of compounds tested was extended to approved metal‐based therapeutics such as silver sulfadiazine and thiomersal, as well as polyoxometalates (POMs). Among the mononuclear metal complexes, only a small number of active inhibitors of the S/ACE2 interaction was identified, with titanocene dichloride as the only strong inhibitor. However, among the gold and silver containing complexes many turned out to be very potent inhibitors of PLpro activity. Highly promising activity against both targets was noted for many POMs. Selected complexes were evaluated in antiviral SARS‐CoV‐2 assays confirming activity for gold complexes with N‐heterocyclic carbene (NHC) or dithiocarbamato ligands, a silver NHC complex, titanocene dichloride as well as a POM compound. These studies might provide starting points for the design of metal‐based SARS‐CoV‐2 antiviral agents.